AbbVie Inc.
NYSE: ABBV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert A. Michael
- Employees
- 55,000
- Headquarters
- North Chicago, United States
- IPO year
- 2013
- Market cap
- $443.6B
- Website
- https://www.abbvie.com
Loading ABBV…
Loading profile data…Frequently asked questions about ABBV
What does AbbVie Inc. (ABBV) do?
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseas...
Where does ABBV trade?
AbbVie Inc. (ABBV) trades on the New York Stock Exchange.
What sector is ABBV in?
AbbVie Inc. (ABBV) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of AbbVie Inc.?
Robert A. Michael is the chief executive officer of AbbVie Inc. (ABBV).
Where is AbbVie Inc. headquartered?
AbbVie Inc. is headquartered in United States.
When did ABBV go public?
AbbVie Inc. (ABBV) completed its initial public offering in 2013.